These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6318382)

  • 61. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
    J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen.
    Hung HH; Su CW; Wu JC; Lee SD
    J Hepatol; 2010 Mar; 52(3):463-5. PubMed ID: 20129689
    [No Abstract]   [Full Text] [Related]  

  • 64. Primary hepatocellular carcinoma and hepatitis B virus.
    Zuckerman AJ
    Trans R Soc Trop Med Hyg; 1982; 76(6):711-8. PubMed ID: 6298981
    [No Abstract]   [Full Text] [Related]  

  • 65. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
    Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R
    Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A prospective cohort study of hepatitis B surface antigen carriers in a working population.
    Iijma T; Saitoh N; Nobutomo K; Nambu M; Sakuma K
    Gan; 1984 Jul; 75(7):571-3. PubMed ID: 6088348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HBsAg, aflatoxins and primary hepatocellular carcinoma.
    Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
    Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The history of hepatitis B virus].
    Scheutz F
    Tandlaegebladet; 1981 Sep; 85(15):459-60. PubMed ID: 6272441
    [No Abstract]   [Full Text] [Related]  

  • 70. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
    Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
    Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects.
    Ricci G; Colombo C; Ghiazza B; Porta C; Moroni M; Illeni MT
    Cancer Lett; 1995 Nov; 98(1):121-5. PubMed ID: 8529200
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?
    Kew MC; Dusheiko GM; Hadziyannis SJ; Patterson A
    Br Med J (Clin Res Ed); 1984 Jun; 288(6432):1727. PubMed ID: 6329398
    [No Abstract]   [Full Text] [Related]  

  • 74. [Role of hepatitis B and delta viruses in the etiology of hepatocarcinoma and other chronic liver diseases].
    Bueno HR; Indacochea S; Oberst RB; Chauca G
    Rev Gastroenterol Peru; 1994; 14(2):135-9. PubMed ID: 7948941
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [HB antigen as a possible factor for causing hepatoma--a pathological viewpoint].
    Shikata T
    Nihon Rinsho; 1974 Dec; 32(12):3509-15. PubMed ID: 4376178
    [No Abstract]   [Full Text] [Related]  

  • 76. Significance of the minor i and t determinants of hepatitis B virus in hepatocellular carcinoma.
    Zhao Y; Oon CJ; Lim GK
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1237-40. PubMed ID: 9918432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B surface antigen in liver tissue and primary liver carcinomas in Thailand.
    Bunyaratvej S; Rochanawutanon M; Chaimuangraj S
    J Med Assoc Thai; 1979 Aug; 62(8):414-21. PubMed ID: 226646
    [No Abstract]   [Full Text] [Related]  

  • 78. Hepatitis B and primary liver cancer.
    Harrison TJ; Chen JY; Zuckerman AJ
    Cancer Treat Rev; 1986 Mar; 13(1):1-16. PubMed ID: 3013403
    [No Abstract]   [Full Text] [Related]  

  • 79. [Seroclearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in hepatitis B virus patients during nucleoside/nucleotide analog therapy].
    Watanabe H; Ueno Y
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():459-65. PubMed ID: 26845978
    [No Abstract]   [Full Text] [Related]  

  • 80. HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles.
    Tseng TC; Kao JH
    Gastroenterology; 2008 Apr; 134(4):1272-3; author reply 1273. PubMed ID: 18395116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.